· Agency action
Joint letters to hospital systems and telehealth providers
Federal Trade Commission and U.S. Department of Health and Human Services, Office for Civil Rights
Primary source: FTC announcement. Checked on November 10, 2026.
The FTC and HHS's Office for Civil Rights warned approximately 130 hospital systems and telehealth providers that tracking technologies such as the Meta/Facebook pixel and Google Analytics may impermissibly disclose health information.
What happened
On July 20, 2023, the Federal Trade Commission and the Office for Civil Rights (OCR) of the U.S. Department of Health and Human Services announced that they had sent a joint letter to approximately 130 hospital systems and telehealth providers about online tracking technologies on their websites and mobile apps. (FTC release, July 20, 2023; HHS release, July 20, 2023.)
The FTC published the letter as a model, with the recipient's name and address left blank. It is signed by the Director of OCR and the Director of the FTC's Bureau of Consumer Protection. It names the Meta/Facebook pixel and Google Analytics as examples of technologies that can track a user's online activities, and it cites research, news reports, OCR's December 2022 bulletin and four FTC enforcement actions: the cases against Easy Healthcare (the Premom app), BetterHelp, GoodRx and Flo Health. (Letter at 1 & nn.1-4, 3.)
The model letter does not say that the recipient violated any law, and neither it nor the FTC's announcement names the recipients. HHS's announcement added that, since the bulletin it issued late in 2022, OCR had confirmed active investigations nationwide. (Letter at 1-3; HHS release, July 20, 2023.)
What the agency did
The letter told recipients that online tracking technologies on their websites or apps may be impermissibly disclosing consumers' sensitive personal health information to third parties. (Letter at 1)
serious privacy and security risks related to the use of online tracking technologies that may be present on your website or mobile application (app)
Letter at 1 The letter said these technologies gather identifiable information about users in ways users often cannot avoid and do not know about. (Letter at 1-2)
often in ways which are not avoidable by and largely unknown to users
Letter at 2 For HIPAA covered entities and business associates, the letter said the HIPAA Rules apply when information collected through tracking technologies or disclosed to tracking vendors includes protected health information, and that regulated entities may not use the technologies in a way that results in impermissible disclosures. (Letter at 2)
HIPAA regulated entities are not permitted to use tracking technologies in a manner that would result in impermissible disclosures of PHI to third parties or any other violations of the HIPAA Rules.
Letter at 2 The letter said that even companies not covered by HIPAA have obligations under the FTC Act and the Health Breach Notification Rule to protect against impermissible disclosures of personal health information, including where a third party built the website or app and where the company does not use the tracking data for marketing. (Letter at 2)
This is true even if you relied upon a third party to develop your website or mobile app and even if you do not use the information obtained through use of a tracking technology for any marketing purposes.
Letter at 2 The letter said that disclosing such information without the consumer's authorization can, in some circumstances, violate the FTC Act and be a breach of security under the Health Breach Notification Rule. (Letter at 2 & n.7)
The disclosure of such information without a consumer’s authorization can, in some circumstances, violate the FTC Act as well as constitute a breach of security under the FTC’s Health Breach Notification Rule.
Letter at 2 The letter listed harms the agencies associate with impermissible disclosures: revealing health conditions, diagnoses, medications and where a person seeks treatment, as well as identity theft, financial loss, discrimination, stigma and mental anguish. (Letter at 2)
Such disclosures can reveal sensitive information including health conditions, diagnoses, medications, medical treatments, frequency of visits to health care professionals, where an individual seeks medical treatment, and more.
Letter at 2 The letter closed by encouraging recipients that use the tracking technologies it describes to review the cited laws and act to protect health information. It did not impose a penalty or require any specific step. (Letter at 3)
we strongly encourage you to review the laws cited in this letter and take actions to protect the privacy and security of individuals’ health information.
Letter at 3 HHS's announcement said that, since the bulletin it issued late in 2022, OCR had confirmed active investigations nationwide. (HHS release, July 20, 2023)
OCR has confirmed its active investigations nationwide to ensure compliance with HIPAA.
HHS release, July 20, 2023
What it did not decide
- Whether any recipient's website or app violated HIPAA, the FTC Act or the Health Breach Notification Rule; the model letter makes no finding about any recipient. (Letter at 1-3.)
- Which website information is protected health information; for HIPAA entities the letter points to OCR's December 2022 bulletin for a general overview of how the HIPAA Rules apply. (Letter at 2.)
- The federal Wiretap Act and state wiretap or privacy statutes; the letter does not discuss them, although a footnote says recipients may also be subject to other state or federal statutes that prohibit disclosing personal health information. (Letter at 3 n.9.)
- Which hospital systems and telehealth providers received the letter; neither the model letter nor the FTC's announcement names them.
The tracking involved
Tools
- Meta/Facebook pixel
- Google Analytics
Data
- identifiable information about users as they interact with a website or mobile app
- information the letter says can reveal health conditions, diagnoses, medications, medical treatments, how often a person sees health care professionals and where a person seeks treatment
How it bears on website tracking claims
Supports: strengthens a website tracking claim on this issue. Limits: narrows or defeats a website tracking claim on this issue. Context: bears on the issue without deciding it either way.
Context: HIPAA
How HIPAA, its criminal provision at 42 U.S.C. § 1320d-6 and HHS guidance bear on tracking.
The letter restates OCR's position that HIPAA regulated entities may not use tracking technologies in a way that results in impermissible disclosures of protected health information, and it relies on OCR's December 2022 bulletin for how the rules apply (Letter at 2). It is a warning, not a ruling, and it does not decide what counts as protected health information on any page. The letter does not mention 42 U.S.C. § 1320d-6, the HIPAA offense some website-tracking claims rely on as the separate wrong, and it does not decide whether any disclosure of individually identifiable health information occurred.
Context: Health information
What counts as individually identifiable health information when it is sent through tracking tools.
The letter lists what impermissible disclosures can reveal, such as health conditions, diagnoses, medications, medical treatments, how often a person sees health care professionals and where a person seeks treatment (Letter at 2). It does not say that any particular page view, click or identifier is health information. In 2024 the court in American Hospital Association v. Becerra vacated the part of OCR's revised bulletin that treated an IP address combined with a visit to an unauthenticated public page about specific conditions or providers as individually identifiable health information, and said the vacatur should not be read to limit the rest of the bulletin.
Context: Consumer protection
Deception and unfair practice claims, such as under the FTC Act and N.Y. General Business Law § 349.
The letter says that even companies outside HIPAA have obligations under the FTC Act and that disclosing health information without the consumer's authorization can, in some circumstances, violate it, pointing to the Easy Healthcare, BetterHelp, GoodRx and Flo Health actions (Letter at 1 n.3, 2 & n.6). It states the agencies' view of FTC Act obligations. It does not address state consumer-protection statutes such as N.Y. General Business Law § 349 or any private claim.
Context: Health Breach Notification Rule
The FTC rule that can treat an unauthorized disclosure of health app data as a breach that requires notice.
The letter says an unauthorized disclosure of health information can be a breach of security under the FTC's Health Breach Notification Rule, citing the Commission's September 2021 statement on health apps and connected devices (Letter at 2 & n.7). The rule reaches vendors of personal health records and related entities that are not covered by HIPAA. The FTC amended the rule effective July 29, 2024, and its definition of breach of security now includes an unauthorized acquisition that results from an unauthorized disclosure (89 Fed. Reg. 47028, 47054).
Context: Standing and injury
Whether the people suing were harmed in a way that lets a federal court hear the claim.
The letter lists harms the agencies associate with impermissible disclosures, including identity theft, financial loss, discrimination, stigma and mental anguish (Letter at 2). That is the agencies' description of risk, not a court's ruling on standing or injury, and it does not address any particular visitor.
Arguments it addresses
- A page visit is not health information
- The letter does not decide that question; for HIPAA entities it points to OCR's bulletin, and a court later vacated the part of the bulletin's March 2024 revision that addressed IP addresses combined with visits to unauthenticated public pages about conditions or providers.
- The company is not a HIPAA covered entity
- The letter says companies outside HIPAA still have obligations under the FTC Act and the Health Breach Notification Rule (Letter at 2).
- A web developer installed the tracking code
- The letter says those obligations apply even if the company relied on a third party to develop its website or app (Letter at 2).
- The company does not use the data for marketing
- The letter says the obligations apply even if the company does not use the information from a tracking technology for any marketing purposes (Letter at 2).
- No regulator has found a violation
- That is accurate for this letter: it warns and encourages review, and the model letter makes no finding about any recipient (Letter at 1-3).
For a company that received a letter
- The letter is a warning from two agencies, not a finding, an order or a court ruling, so it shows the agencies' stated position as of July 2023.
- It addresses two regimes: HIPAA for covered entities and business associates, and the FTC Act and the Health Breach Notification Rule, which it says apply even to companies not covered by HIPAA.
- Its HIPAA discussion rests on OCR's tracking bulletin, which OCR revised in March 2024 and a court partly vacated in June 2024, so the bulletin's current text and that ruling are its companion documents.
What to check on your own site
- List every tracking technology on the website and apps, including the Meta/Facebook pixel and Google Analytics named in the letter, and the pages and screens where each one runs.
- Include tags added by a website developer, agency or vendor, since the letter says relying on a third-party developer does not change the obligations it describes.
- Check what each tag sends from pages about conditions, treatments, medications and locations of care, the categories the letter says disclosures can reveal.
Later history
OCR revised the bulletin cited in the letter on March 18, 2024. On June 20, 2024, in American Hospital Association v. Becerra, No. 4:23-cv-01110-P (N.D. Tex.), the court declared unlawful and vacated the part of the revised bulletin addressing an IP address combined with a visit to an unauthenticated public webpage about specific health conditions or health care providers, and said the vacatur should not be read to limit the rest of the bulletin (ECF No. 67 at 3-4, 31 & n.8). The FTC's amendments to the Health Breach Notification Rule took effect on July 29, 2024 (89 Fed. Reg. 47028). HHS appealed the American Hospital Association ruling on August 19, 2024, and the Fifth Circuit dismissed the appeal on HHS's motion on September 4, 2024 (No. 24-10775; ECF Nos. 69, 71).
Sources
- FTC announcement (July 20, 2023)
- Model letter: Use of Online Tracking Technologies
- HHS announcement (July 20, 2023)
- Court order vacating part of the revised HHS bulletin (ECF No. 67, June 20, 2024)
- Federal Register: Health Breach Notification Rule (May 30, 2024)
- Docket in American Hospital Association v. Becerra, including the notice of appeal and the dismissal (ECF Nos. 69, 71)
Related rulings
Published by Privacy Resolve from public records. It does not cover our own matters.
General information only, not legal advice, and not a substitute for the advice of an attorney. Laws, deadlines, defenses and outcomes vary by jurisdiction and facts.